Vanguard Group’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Vanguard Group’s Portfolio OCEA Stock Details OCEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-406,529	Closed	-$22K	–	4347
2025 Q1	$22K	Hold	406,529	–	–	﹤0.01%	4240
2024 Q4	$225K	Hold	406,529	–	–	﹤0.01%	4081
2024 Q3	$398K	Hold	406,529	–	–	﹤0.01%	4028
2024 Q2	$496K	Buy	406,529 +135,877	+50%	+$232K	﹤0.01%	4008
2024 Q1	$1.02M	Buy	270,652 +118,655	+78%	+$223K	﹤0.01%	3802
2023 Q4	$100K	Buy	151,997 +11,360	+8%	+$15.6K	﹤0.01%	4298
2023 Q3	$548K	Buy	140,637 +99,014	+238%	+$455K	﹤0.01%	4026
2023 Q2	$250K	Buy	+41,623	New	+$244K	﹤0.01%	4273

Other funds holding OCEA

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Vanguard Personalized Indexing Management Oakland, California $12.2B AUM 47.93% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

SMA

Sage Mountain Advisors Atlanta, Georgia $1.63B AUM 18.97% 1-Year Est. Return

Vanguard Group's OCEA Position: Q2 2025 in Review

Vanguard Group sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2025, closing a stake of 406,529 shares — an estimated $22K sold.

Vanguard Group first reported a position in OCEA in Q2 2023 and held it in 8 quarters. The position peaked at $1.02M in Q1 2024. 7 funds tracked by Wall St. Rank hold OCEA as of Q2 2025.

Vanguard Group reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
Vanguard Group sold 406,529 Ocean Biomedical, Inc. Common Stock shares in Q2 2025, an estimated $22K.
Vanguard Group first reported a position in Ocean Biomedical, Inc. Common Stock in Q2 2023 and held it in 8 quarters.
Vanguard Group's Ocean Biomedical, Inc. Common Stock position peaked at $1.02M in Q1 2024.
7 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2025.

Based on Vanguard Group's 13F filing for Q2 2025, filed 11 Aug 2025.